1 马莉,岳华,李定霏.siRNA干涉禽流感病毒在鸡胚成纤维细胞中基因表达的影响[A].中国畜牧兽医学会禽病学分会第十四次学术研讨会论文集[C].1996. 2 王文,邓瑶,谭文杰,等.人禽流感病毒H5N1多价重组痘苗病毒(天坛株)疫苗在小鼠中的免疫原性研究[J].中华微生物学和免疫学杂志,2010,30(6):546~550. 3 王国俊,熊杰,李俊平,等.H5亚型禽流感病毒A/Duck/Anhui/1/2006(Clade 2.3)密码子优化HA基因DNA疫苗的免疫保护效力研究[J].中国预防兽医学报,2010,32(2):116~120. 4 王振国,金宁一,马鸣潇,等.共表达H5、H7亚型AIV HA基因与鸡IL-18基因的重组鸡痘病毒构建[J].高技术通讯,2006,16(4):408~413. 5 布日额,吴金花,孙立杰,等.禽流感病毒A/duck/Fujian/31/2007(H5N1)株M1基质蛋白的原核表达与免疫原性鉴定[J].中国畜牧兽医,2012,39(6):46~49. 6 田国彬,曾显营,钟功勋,等.H5N1亚型禽流感变异株灭活疫苗种毒Re-4株的生物学特性及免疫原性研究[J].中国预防兽医学报,2009,31(9):717~720. 7 刘志辉,姜涛,秦鄂德,等.流感疫苗研制的新策略[J].生物工程学报,2012, 28(5): 550~556. 8 刘春国,刘明,孙恩成,等.密码子优化的H5亚型流感病毒HA基因重组质粒在哺乳动物细胞中的高效表达及其免疫原性的研究[J].自然科学进展,2009,19(8):813~818. 9 孙鹏,王云峰,胡桂学.禽痘病毒载体及其应用[J].中国畜牧兽医,2010,37(9):82~84. 10 吴蒙,刘宇鸽,李改瑞,等.H5N1禽流感病毒HA与NA基因克隆及分泌表达[J].中国公共卫生,2011,27(1):37~39. 11 张芳芳,姜永萍,刘光亮,等.表达禽流感病毒H5 HA、H7 HA基因DNA疫苗的免疫原性研究[J].中国预防兽医学报,2006,28(1):1~5. 12 李明义,范根成,杜元钊,等.禽流感(H5、H9亚型)二价油乳剂灭活疫苗实验研究[J].中国动物检疫,2005,22(4):25~27. 13 杨忠东,王石磊,许文婷,等.禽流感H5N1灭活疫苗与不同纳米化佐剂联合免疫研究[J].国际生物制品学杂志,2011,34(3):126~129. 14 罗孟成,陶攀,肖庚富,等.H5N1亚型禽流感病毒核蛋白NP的原核表达及抗体制备[J].中国人兽共患病学报,2008,24(3):202~209. 15 赵晓民,张强哲,段明星,等.H5N1亚型禽流感病毒HA基因DNA疫苗的构建和活体电击免疫试验初报[J].中国农学通报,2005,21(5):78~80. 16 徐小艳,王相子,徐正军,等.重组禽流感病毒H5亚型二价灭活疫苗免疫抗体监测与分析[J].畜牧与兽医,2011,43(6):50~52. 17 徐爱平,黎晓敏.纳米氢氧化铝吸附禽流感病毒灭活疫苗的研制及其对肉鸡抗体效价的影响[J].中国兽医学报,2012,32(2):189~195. 18 贾立军,张艳梅,李军伟,等.H5亚型禽流感重组鸡痘病毒活载体疫苗的免疫效力[J].扬州大学学报(农业与生命科学版),2003,24(2):11~13. 19 高宏博,催红玉,石星明,等.表达H5亚型禽流感病毒HA基因重组火鸡疱疹病毒的构建[J].中国预防兽医学报,2010,32(5):329~333. 20 游猛,潘志明,方强,等.展呈H5N1亚型禽流感病毒M2e表位鞭毛蛋白的构建及其免疫原性[J].中国兽医科学,2012,42(2):119~125. 21 樊树芳.H5N1亚型禽流感病毒弱毒活疫苗株构建及在不同动物模型上免疫效力的评价[D].北京:中国农业科学院,2008. 22 Alexander D J, Brown I H. History of highly pathogenic avian influenza[J]. Rev Sci Tech, 2009, 28(1): 19~38. 23 Dong L, Liu F, Fairman J, et al. Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice[J]. Vaccine, 2012, 30(2): 254~264. 24 Fan Y, Wang D, Liu J, et al. Adjuvanticity of epimedium polysaccharide-propolis flavone on inactivated vaccines against AI and ND virus[J]. Int J Biol Macromol, 2012, 51(5): 1028~1032. 25 Ge Q, McManus M T, Nguyen T, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription[J]. Proc Natl Acad Sci USA, 2003, 100(5): 2718~2723. 26 Jazayeri S D, Ideris A, Zakaria Z, et al. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier[J].Comp Immunol Microbiol Infect Dis, 2012, 35(5): 417~427. 27 Li W X, Li H, Lu R, et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing[J]. Proc Natl Acad Sci USA, 2004, 101(5): 1350~1355. 28 Lim K L, Jazayeri S D, Yeap S K, et al. Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses[J]. BMC Vet Res, 2012, 8:132~145. 29 Lin Y J, Deng M C, Wu S H, et al. Baculovirus-derived hemagglutinin vaccine protects chickens from lethal homologous virus H5N1 challenge[J]. J Vet Med Sci, 2008, 70(11): 1147~1152. 30 Lin S C, Huang M H, Tsou P C, et al. Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines[J]. PLoS One, 2011: 6(5): e20052. 31 Liu J, Chen P, Jiang Y, et al. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks[J]. J Virol, 2011, 85(21): 10989~10998. 32 Nang N T, Song B M, Kang Y M, et al. Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses[J]. Influenza Other Respi Viruses, 2013, 7(2):120~131. 33 Patel A, Gray M, Li Y, et al. A co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection[J]. Vaccine, 2012, 30(3): 626~636. 34 Qian C, Chen S, Ding P, et al. The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks[J] Vaccine, 2012, 30(44): 6279~6286. 35 Qiao C L, Yu K Z, Jiang Y P, et al. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 hemagglutinin and N1 neuraminidase genes[J]. Avian Pathol, 2003, 32(1): 25~31. 36 Qiao C L, Jiang Y P, Tian G, et al. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus[J]. Antiviral Res, 2009, 81(3): 234~238. 37 Saha S, Yoshida S, Ohba K, et al. A fused gene of nucleoprotein and herpes simplex virus genes induces highly protective immunity against different subtypes of influenza virus[J]. Virology, 2006, 354(1): 48~57. 38 Saha R, Killian S, Donofrio R S. DNA vaccines: A mini review[J]. Recent Pat DNA Gene Seq, 2011, 5(2): 92~96. 39 Song M S, Moon H J, Kwon H I, et al. Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models[J]. J Microbiol, 2012a, 50(3): 478~488. 40 Song B H, Yun G N, Kim J K, et al. Biological and genetic properties of SA(14)-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans[J].J Microbiol, 2012b, 50(4): 698~706. 41 Tian G, Zhang S, Li Y, et al. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics[J]. Virology, 2005, 341(1): 153~162. 42 Wang S, Hackett A, Jia N, et al. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicitcross-protective antibody responses[J]. PLoS One, 2011, 6(12): e28757. 43 Wang Z, Gao J, Yu Q, et al. Oral immunization with recombinant lactococcuslactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses[J]. Future Microbiol, 2012, 7(8): 1003~1010. 44 Xu K, Ling Z Y, Sun L, et al. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus[J]. Viral Immunol, 2011, 24(1): 45~56. 45 Xue L X, Pan W D, Jiang G Z, et al. Transgenic Dunuliella salina as a bioreactor[P].US Patent 7081567 B2, 2006. 46 Zhang X, Liu M, Liu C, et al. Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens[J]. Intervirology, 2011, 54(5): 290~299. 48 Zhou K, He H, Wu Y, et al. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids[J]. J Biotechnol, 2008, 135(2): 140~144. 47 Zhou F, Wang G, Buchy P, et al. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses[J]. J Virol, 2012, 86(12): 6970~6978. |